Mads Bodenhoff, Senior Vice President and Principal Accounting Officer, on September 08, 2026, sold 3,000 shares in Ascendis Pharma (ASND) for $810,570.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1612042/000161071726000409/xslF345X05/form4.xml